images of individual dose volume histograms and dose distributions of patients. (DOCX 15022 kb
Figure S1. The relationship of absorbed dose measured by Fricke dosimeter as a function of exposure ...
Table S1. Optimal respiratory gating impacts the quantification of [18F]FDG PET-derived image featur...
Table S1. Quantitative parameters on the pre-treatment PET1 scan and inter-fractional PET2 scan. (DO...
Quality volume histograms of the five patients for planning phase I. (DOCX 116 kb
Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous cell car...
Tables S2aâ+âb. 1. FLAME protocol / 2. Pinkawa protocol. Dose characteristics after IMRT plannin...
Table S1. Spearman’s Rho values between DCE-MRI/IVIM-DWI at baseline and anthropometric variables at...
PURPOSE: Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous...
Table S1. The comparison of the 3D globe, and organ-specific GP (%) calculated with local dose norma...
Figure. S1. Figure showing the isodose line of 20âGy (outlined in yellow) and 5âGy (outlined in ...
Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...
Figure S1. Scatter plots of IVIM-DWI parameters versus Age and BMI. Figure S2. Scatter plots of DCE-...
The dose constraints to organs at risk (OARs). Abbreviations: OAR organ at risk, PRV planning organ ...
Table S1. Spearmanâs Ď correlations and scatter map between dosimetric parameters. (DOCX 561 kb
Generating treatment bootstrap samples from random positioning uncertainty for IG-IMRT and IMRT trea...
Figure S1. The relationship of absorbed dose measured by Fricke dosimeter as a function of exposure ...
Table S1. Optimal respiratory gating impacts the quantification of [18F]FDG PET-derived image featur...
Table S1. Quantitative parameters on the pre-treatment PET1 scan and inter-fractional PET2 scan. (DO...
Quality volume histograms of the five patients for planning phase I. (DOCX 116 kb
Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous cell car...
Tables S2aâ+âb. 1. FLAME protocol / 2. Pinkawa protocol. Dose characteristics after IMRT plannin...
Table S1. Spearman’s Rho values between DCE-MRI/IVIM-DWI at baseline and anthropometric variables at...
PURPOSE: Validation of dose escalation through FDG-PET dose painting (DP) for oropharyngeal squamous...
Table S1. The comparison of the 3D globe, and organ-specific GP (%) calculated with local dose norma...
Figure. S1. Figure showing the isodose line of 20âGy (outlined in yellow) and 5âGy (outlined in ...
Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...
Figure S1. Scatter plots of IVIM-DWI parameters versus Age and BMI. Figure S2. Scatter plots of DCE-...
The dose constraints to organs at risk (OARs). Abbreviations: OAR organ at risk, PRV planning organ ...
Table S1. Spearmanâs Ď correlations and scatter map between dosimetric parameters. (DOCX 561 kb
Generating treatment bootstrap samples from random positioning uncertainty for IG-IMRT and IMRT trea...
Figure S1. The relationship of absorbed dose measured by Fricke dosimeter as a function of exposure ...
Table S1. Optimal respiratory gating impacts the quantification of [18F]FDG PET-derived image featur...
Table S1. Quantitative parameters on the pre-treatment PET1 scan and inter-fractional PET2 scan. (DO...